173 related articles for article (PubMed ID: 18292476)
1. Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers--initial results.
Bali MA; Metens T; Denolin V; De Maertelaer V; Devière J; Matos C
Radiology; 2008 Apr; 247(1):115-21. PubMed ID: 18292476
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
[TBL] [Abstract][Full Text] [Related]
3. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic transplants: secretin-stimulated MR pancreatography.
Boraschi P; Donati F; Gigoni R; Odoguardi F; Neri E; Boggi U; Falaschi F; Bartolozzi C
Abdom Imaging; 2007; 32(2):207-14. PubMed ID: 17401601
[TBL] [Abstract][Full Text] [Related]
6. Renal perfusion 3-T MR imaging: a comparative study of arterial spin labeling and dynamic contrast-enhanced techniques.
Wu WC; Su MY; Chang CC; Tseng WY; Liu KL
Radiology; 2011 Dec; 261(3):845-53. PubMed ID: 22095996
[TBL] [Abstract][Full Text] [Related]
7. Dynamic non-invasive ASL perfusion imaging of a normal pancreas with secretin augmented MR imaging.
Schawkat K; Ith M; Christe A; Kühn W; Chittazhathu Y; Bains L; Runge VM; Heverhagen JT
Eur Radiol; 2018 Jun; 28(6):2389-2396. PubMed ID: 29302785
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic duct: morphologic and functional evaluation with dynamic MR pancreatography after secretin stimulation.
Matos C; Metens T; Devière J; Nicaise N; Braudé P; Van Yperen G; Cremer M; Struyven J
Radiology; 1997 May; 203(2):435-41. PubMed ID: 9114101
[TBL] [Abstract][Full Text] [Related]
9. Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement.
Akisik MF; Aisen AM; Sandrasegaran K; Jennings SG; Lin C; Sherman S; Lin JA; Rydberg M
Radiology; 2009 Jan; 250(1):103-9. PubMed ID: 19001148
[TBL] [Abstract][Full Text] [Related]
10. Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging.
Sourbron S; Sommer WH; Reiser MF; Zech CJ
Radiology; 2012 Jun; 263(3):874-83. PubMed ID: 22623698
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of chronic pancreatitis by using apparent diffusion coefficient measurements at 3.0-T MR following secretin stimulation.
Akisik MF; Sandrasegaran K; Jennings SG; Aisen AM; Lin C; Sherman S; Rydberg MP
Radiology; 2009 Aug; 252(2):418-25. PubMed ID: 19508986
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic duct after pancreatoduodenectomy: morphologic and functional evaluation with secretin-stimulated MR pancreatography.
Monill J; Pernas J; Clavero J; Farré A; Morales A; González M; Artigas V; Martínez-Noguera A
AJR Am J Roentgenol; 2004 Nov; 183(5):1267-74. PubMed ID: 15505290
[TBL] [Abstract][Full Text] [Related]
13. Correlation between pancreatic microcirculation and type 2 diabetes in patients with coronary artery disease: dynamic contrast-enhanced MR imaging.
Yu CW; Shih TT; Hsu CY; Lin LC; Wei SY; Lee CM; Lee YT
Radiology; 2009 Sep; 252(3):704-11. PubMed ID: 19717751
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic transplants: noninvasive evaluation with secretin-augmented mr pancreatography and MR perfusion measurements--preliminary results.
Heverhagen JT; Wagner HJ; Ebel H; Levine AL; Klose KJ; Hellinger A
Radiology; 2004 Oct; 233(1):273-80. PubMed ID: 15454624
[TBL] [Abstract][Full Text] [Related]
15. Temporal assessment of pancreatic blood flow and perfusion following secretin stimulation using noninvasive MRI.
Cox EF; Smith JK; Chowdhury AH; Lobo DN; Francis ST; Simpson J
J Magn Reson Imaging; 2015 Nov; 42(5):1233-40. PubMed ID: 25787269
[TBL] [Abstract][Full Text] [Related]
16. Assessment of exocrine pancreatic function by secretin-stimulated magnetic resonance cholangiopancreaticography and diffusion-weighted imaging in healthy controls.
Wathle GK; Tjora E; Ersland L; Dimcevski G; Salvesen ØO; Molven A; Njølstad PR; Haldorsen IS
J Magn Reson Imaging; 2014 Feb; 39(2):448-54. PubMed ID: 23649590
[TBL] [Abstract][Full Text] [Related]
17. Colorectal liver metastases: contrast agent diffusion coefficient for quantification of contrast enhancement heterogeneity at MR imaging.
Jia G; O'Dell C; Heverhagen JT; Yang X; Liang J; Jacko RV; Sammet S; Pellas T; Cole P; Knopp MV
Radiology; 2008 Sep; 248(3):901-9. PubMed ID: 18710983
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary circulation: contrast-enhanced 3.0-T MR angiography--initial results.
Nael K; Michaely HJ; Kramer U; Lee MH; Goldin J; Laub G; Finn JP
Radiology; 2006 Sep; 240(3):858-68. PubMed ID: 16837670
[TBL] [Abstract][Full Text] [Related]
19. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity.
Horsthuis K; Lavini C; Bipat S; Stokkers PC; Stoker J
Radiology; 2009 May; 251(2):380-7. PubMed ID: 19401571
[TBL] [Abstract][Full Text] [Related]
20. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience.
Krautmacher C; Willinek WA; Tschampa HJ; Born M; Träber F; Gieseke J; Textor HJ; Schild HH; Kuhl CK
Radiology; 2005 Dec; 237(3):1014-9. PubMed ID: 16237142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
